Trial Site News
Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages
  • Register
  • Log In
  • News
  • Video
  • Podcast
  • More
Trial Site News
  • News For You
  • Op-Eds
  • Video
  • Podcasts
  • Investor Watch
  • Write for us
  • News for You
  • Op-Eds
  • Video
  • Podcasts
  • Covid-19
  • Investor Watch

Topic: Avigan

Back to the Drawing Board for Fujifilm Holdings’ Favipiravir in Japan as it Must Now Execute Another Phase 3 Clinical Trial

Japanese drug regulatory authorities failed to make a decision on whether favipiravir (Avigan) would be used as a treatment for […]

Back to the Drawing Board for Fujifilm Holdings’ Favipiravir in Japan as it Must Now Execute Another Phase 3 Cliicial Trial
1 week ago
Share

Favipiravir Fails to Help Moderate to Severe Hospitalized COVID-19 Cases However May Lead to Modest Reduction in Duration of Hospitalization

A Kuwait-based clinical trial sponsored by Indian generic drug producer Dr. Reddy’s Laboratory was recently terminated as the resulting data […]

Favipiravir Fails to Help Moderate to Severe Hospitalized COVID-19 Cases However May Lead to Modest Reduction in Duration of Hospitalization
1 month ago
Share

Rwanda Yet Another Country to Accept Favipiravir as a Repurposed Oral Treatment for COVID-19

Yet another nation has opted to embrace the antiviral drug Favipiravir (Avigan) as a treatment for early onset COVID-19.  Approved […]

Rwanda Yet Another Country to Accept Favipiravir as a Repurposed Oral Treatment for COVID-19
1 month ago
Share

Generic Drug Giant Quietly Submits Marketing Authorization Application for Reeqonus (Favipiravir) in Canada

Health Canada may be following India, Russia, some nations in Eastern Europe, and dozens of other nations who opt to […]

Generic Drug Giant Quietly Submits Marketing Authorization Application for Reeqonus (Favipiravir) in Canada
2 months ago
Share

Will Favipiravir get Authorized in Japan for COVID-19? No Slam Dunk as Authorities Point to Inconclusive Data

Japanese health authorities are struggling to reach a decision as to whether favipiravir (Avigan) is effective as treatment for COVID-19 […]

Will Favipiravir get Authorized in Japan for COVID-19 No Slam Dunk as Authorities Point to Inconclusive Data
3 months ago
Share

Can Avigan (Favipiravir) Prevent SARS-CoV-2 Infection? Canadian Sponsor Given Greenlight by Health Canada & FDA to Find Out

Publicly traded Appili Therapeutics out of Canada, a biotech venture attempting to commercialize Avigan® tablets (favipiravir), the antiviral drug originating […]

Can Avigan (Favipiravir) Prevent SARS-CoV-2 Infection Canadian Sponsor Given Greenlight by Health Canada & FDA to Find Out
3 months ago
Share

Mumbai Hospital-led Phase 3 Clinical Trial Reveals the Efficacy of Favipiravir Targeting Mild to Moderate COVID-19 Patients in India

Glenmark Pharmaceuticals, a prominent Indian pharmaceutical firm, reports that the oral antiviral drug originating in Japan, Favipiravir, prevents the replication […]

Mumbai Hospital-led Phase 3 Clinical Trial Reveals the Efficacy of Favipiravir Targeting Mild to Moderate COVID-19 Patients in India
3 months ago
Share

Progress for Favipiravir? Appili Therapeutics Inks Licensing Deal with Dr. Reddy’s Laboratories

Appili Therapeutics Inc. (TSX: APLI; OTCQX: APLIF) (the “Company” or “Appili”), a biopharmaceutical company focused on anti-infective drug development, today […]

Progress for Favipiravir Appili Therapeutics Inks Licensing Deal with Dr. Reddy’s Laboratories
4 months ago
Share

Russia Approves Three Favipiravir-based Drugs for COVID-19 While IL-6 inhibiting mAb ‘Registered” back in June

The Russian Federal Service for Surveillance in Healthcare recently announced the permanent registration of three drugs targeting COVID-19, all based […]

Russia Approves Three Favipiravir-based Drugs for COVID-19 While IL-6 inhibiting mAb ‘Registered” back in June
4 months ago
Share

Ukraine Ministry of Health to Formally Register Favipiravir as a COVID-19 Treatment

TrialSite reported that in Russia, the Ministry of Health approved the generic form of Favipiravir, the Japanese generic of the […]

Ukraine Ministry of Health to Formally Register Favipiravir as a COVID-19 Treatment
4 months ago
Share

Posts navigation

Older posts

Latest Podcasts

Alan Cannell talks COVID-19: Nobody Likes Cheap Solutions | Podcast S2 E41

Dr. Pierre Kory Talks Covid-19, Ivermectin and the FLCCC | Podcast E43

An Interview With Patricia Carter: Patient Engagement and Retention in Clinical Trials

Dr. Negin Hajizadeh: Researchers Finding A Very Effective Treatment For Covid-19 In New Study

Dr. Jean-Jacques Rajter and Dr. Juliana Cepelowicz Rajter Discuss Ivermectin In Broward County | Podcast S2 E 27

159 W Broadway, Suite 200
Salt Lake City, UT 84101

[email protected]

Connect With Us

TRIALSITE NEWS IS THE ONLY DIGITAL MEDIA DEDICATED 100% TO TRANSPARENT AND OPEN COVERAGE OF CLINICAL RESEARCH TRIAL SITES AROUND THE GLOBE. BASED IN THE SILICON SLOPES IN DOWNTOWN SALT LAKE CITY, UTAH, WE ARE FOUNDED BY A TEAM OF EXPERTS IN THE CLINICAL TRIALS INDUSTRY AND DEDICATED TO TRANSPARENCY, QUALITY AND CLINICAL TRIAL INNOVATION.

© 2021 TRIALSITE NEWS. ALL RIGHTS RESERVED.